Best, Shawn

cc ce ee ee ee ee ee ee ee oe
ee ce ee me ee ee ee ee ee ree we ee ee ey ee ee ee ee

Shawn O'Neail
Vice President, Government Affairs
El ws and Company

 
 

CL. © (mobile)
(6) | >wwwililly.com<

CONFIDENTIALITY NOTICE: This e-mail nessage (including all attachments) is for the sole use of
the intended recipiert(s) and may contain confidential and privileged information. Any unauthorized
review, use, disclosure, copying or cistribution is strictly prohibited. If you are not the intended
recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

From: Grogan, Joseph J. EOP/WHO [>

Sent: Tuesday, April 7, 2020 9:31 AM

To: Shawn O'Neailf—____ ©) (J Bonner, Maria K. EOP/WHO
a C1 ()

Subject: [EXTERNAL] RE: Good news

 

EXTERNAL EMAIL: Use caution before replying, clicking links, and
opening attachments.

This is great. Thank you for sharing and everything you are doing. Joe

From: Shawn O'Neail
Sent: Tuesday, April 7, 2020 9:26 AM

To: Grogan, Joseph J. EOP/WHO[ 8) FF} Bonner, Maria K.
EOP/WHO (>

Subject: [EXTERNAL] Good news
Hi Joe and Maria

| want to share an important update about Lilly's efforts to address insulin affordability. In
response to the crisis caused by COVID-19, Lilly is introducing the Lilly Insulin Value
Program, allowing anyone with commercial insurance - and those without insurance - to
fill their monthly prescription of Lilly insulin for $35. The program is effective today and
covers most Lilly insulins. Details and more information can be found in the press release
here attached.

Lilly has introduced several solutions in recent years to help meet the individual financial
circumstances of people living with diabetes that are still in effect during the COVID-19
crisis, including:
